Joyce Pagan

Optimal supportive care that includes patient education and anticipatory management of common adverse effects (AE) can improve adherence to treatment protocols and result in better response rates in patients receiving selinexor for relapsed/refractory multiple myeloma (MM). These findings were demonstrated in an adverse effect (AE) management protocol presented during the Oncology Nursing Society (ONS) Bridge,…

The editors present an interview with Joanna Morales of Cancer Triage featuring questions from attendees of the 2020 ONA Virtual Navigation Summit.

A cancer rights attorney explains the basics of health insurance options available to patient with cancer who do not have employer-sponsored health insurance.

Nurse-led protocol maintains hematology-oncology patient safety with VSM extended to once every 8 hours.

Structured palliative care can ensure these patients and their caregivers have an optimal experience that does not hinder trial outcomes.

Using remote communications technology, a major cancer center was able to manage symptoms in high-risk patients initiating treatment at a regional location.

SARP, a novel wearable monitoring platform, gave clinicians a supplementary opportunity to monitor patient health and assess risk in patients of advanced age undergoing treatment for cancer.

Review of responses to clinical trial prompts within an oncology clinical pathways system identified barriers to increasing patient enrollment in clinical trials.

Readmissions for CRS, neurotoxicity, infection, and other adverse events are common after immunotherapy with axicabtagene ciloleucel.

Researchers surveyed consecutive new patients at a multidisciplinary clinic to determine smokers’ willingness to participate in a cessation program.